An interventional study of Cervical Joint Mobilization in Neck Pain Musculoskeletal and Neck Pain, sponsored by Sharon Wang-Price. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Sharon Wang-Price · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to assess the immediate effects of cervical joint mobilization on patients experiencing neck-shoulder pain.
The main research questions are: (1) Does the joint mobilization intervention acutely change blood flow in the neck/shoulder area? (2) Does the joint mobilization intervention acutely increase pressure pain thresholds (PPTs)? (3) Does the joint mobilization intervention acutely increase cervical range of motion (ROM)? (4) Does the joint mobilization intervention acutely decrease the number of tender and hypertonic points?
This study utilizes a single-session, pre- and post-intervention design with no comparison group. Participants will attend one on-site visit (1.25 hours) for screening and intervention. First, each eligible participant will complete an intake form for demographics and three questionnaires: the Brief Pain Index (BPI), Neck Disability Index (NDI), and Central Sensitization Inventory (CSI).
Following the questionnaires, participants will undergo baseline assessments for their tender and hypertonic points, cervical ROMs, PPTs, and blood flow parameter. After the baseline assessments, each participant will receive a lateral glide oscillatory joint mobilization technique to the C4-C5 level for five minutes. Immediately following the intervention, all four outcome measures, including tender points, cervical ROM, PPTs and blood flow parameters will be re-assessed.
All participants are required to attend one on-site visit (\~ 1.25 hours). The procedures of this research study are described as follows:
Administration of the Consent Form, Intake Form and Questionnaires At the beginning of the on-site visit, one investigator will describe the study purpose/procedures as well as the risks/benefits associated with this study to each participant. Once the participant agrees to participate in this study, the participant will be asked to sign the written consent form. Next, the participant will complete an intake form for their demographic information and the history of their neck-shoulder pain. Each participant also will complete 3 questionnaires: (1) Brief Pain Index (BPI), (2) Neck Disability Index (NDI) and (3) Central Sensitization Inventory (CSI). These 3 questionnaires will provide information of each participant's neck-shoulder pain, function level and degree of central sensitization/segmental facilitation.
The BPI is a 9-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The NDI is a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The CSI consists of two parts: Part A is a 25-item self-report questionnaire designed to identify patients who have symptoms that may be related to central sensitization. Part B asks patients whether they have been diagnosed with 10 central sensitization syndromes, such as fibromyalgia, whiplash and migraine.
1,363 studies on the registry are indexed under Neck Pain; 300 are open to participants now.
This study's planned enrollment of 30 is below the median of 50 across 1,117 interventional studies indexed under Neck Pain.
Browse Neck Pain studies →Sharon Wang-Price is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
C4-5 non-thrust, oscillatory joint mobilization
Procedure: Cervical Joint Mobilization
C4-5 non-thrust, oscillatory joint mobilization
Blood flow - Peak Systolic Velocity
Peak systolic velocity (PSV) will be used to determine the status of blood flow. A color Doppler ultrasonographic scanner (Sonosite PX, FUJIFILM Sonosite, Inc., Bothell, WA) and a linear transducer (6 cm, 19-5 MHz) will be used to determine PSV of the transverse cervical artery. The spectral Doppler waveforms will be automatically generated by the US scanner, displaying the velocities of blood flow in the dorsal scapular artery throughout the cardiac cycle. Three US images will be taken and the average of the three trials will be used for data analysis.
Time frame: On the same day, this outcome measure will be collected twice: (1) Baseline, pre-intervention (2) Immediately after the intervention
Pressure pain threshold
Pressure pain threshold (PPT) of the levator scapula muscle will be determined handheld computerized pressure algometer (Medoc Ltd, Ramat Yishai, Israel). The testing site will be near the insertion of the levator scapula (i.e., superomedial border of the scapula). The algometer consists of a 1-cm squared round tip that will be pressed vertically over the testing site. The participant will be instructed to hold the response unit in the non-testing hand and press the button once the sensation of pressure changes to a sensation of pain. A total of 4 trials will be performed, and the average of the last 3 trials will be used for data analysis.
Time frame: On the same day, this outcome measure will be collected twice: (1) Baseline, pre-intervention (2) immediately after the intervention
Cervical motions
Six cervical range of motion of flexion, extension, left and right rotations, and left and right side-flexions will be assessed using a CROM device (Fabrication Enterprises Inc., White Plains, NY). Each participant will perform each of six motions twice and the average of the two trials will be used for data analysis.
Time frame: On the same day, this outcome measure will be collected twice: (1) Baseline, pre-intervention (2) Immediately after the intervention
Number of tender points
Four sites will be assessed for tenderness and hypertonicity, including (1) upper cervical segments (C1-C2), (2) C4-5 segment, (3) levator scapulae near the insertion, and (4) the middle of supraspinatus/upper trapezius muscles. An investigator will palpate these four sites to determine the existence of tenderness and hypertonicity and tender points.
Time frame: On the same day, this outcome measure will be collected twice: (1) Baseline, pre-intervention (2) Immediately after the intervention
No study locations are listed for this record.
Plan to share: No — Because some participants may not consent to broad data sharing.
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Aug 2027, 7 months later.
Of 763 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 7 months is close to that.
Counting every sponsor, half of 772 studies reached it within 7 months; a quarter within 3 and three quarters within 15.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sharon Wang-Price